Stopping heart meds after recovery from fast heartbeat damage
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests if patients whose heart function returned to normal after treating a fast heartbeat can safely stop their heart failure medications. It aims to see if treatment can be withdrawn without the heart problems coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have new heart failure with a weak heart pump (ejection fraction 40% or less) and symptoms like shortness of breath or fatigue (NYHA class 2 or higher).
- You have atrial fibrillation or flutter with a heart rate of 110 beats per minute or faster.
- After treating the fast heartbeat (e.g., with ablation or medication), your heart function improved: ejection fraction is now 50% or more, your heart size normalized, your ECG is normal, and a blood test (NT-proBNP) is below 250 pg/ml.
- You are 18 or older and can give consent.
- You do not have significant heart valve disease, inherited heart muscle disease, or other serious heart conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether patients whose heart function has fully recovered after surgery or a heart procedure can safely reduce or stop their heart failure medications. Researchers will carefully monitor whether gradually lowering these medicines is safe and maintains heart health.
This trial studies whether patients with non-ischemic cardiomyopathy who have responded extremely well to a special pacemaker (CRT) can safely stop their heart failure medications. It aims to see if their heart function stays stable without these drugs.
This trial is testing whether people whose heart failure has improved (with better pumping strength) can safely stop taking some of their heart medications. It is for stable patients who have had significant improvement in their heart function from a low point.
This trial tests a procedure called pulmonary artery denervation (using a catheter to treat nerves in the lung's blood vessels) for people with heart failure who still have a preserved ejection fraction (their heart squeezes normally but doesn't fill properly). The procedure aims to reduce pressure in the lungs and improve symptoms like shortness of breath. Participants must be on stable heart failure medications and have elevated BNP levels, among other requirements.
This trial tests whether it is safe to slowly reduce some heart failure medications for people whose heart function has improved to normal. It is for patients who once had a weak heart pump but now have recovered strength and are stable on multiple medicines.
This study looks at whether patients with severe heart failure follow their prescribed medications as recommended by treatment guidelines. The researchers want to understand what helps or prevents patients from taking their medicines correctly, which could improve their heart function and symptoms.
Hear when a new Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.